Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04573062 · ClinicalTrials.gov registry record
Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health
A clinical trial of Post-Coronavirus Disease 19, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Recruiting
- Registry status
- 1,590
- Enrollment target
- 1
- Study location
NCT04573062 is a study of Post-Coronavirus Disease 19 that is actively recruiting participants, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 1,590 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04573062, a study of Post-Coronavirus Disease 19, is actively recruiting participants, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- RECRUITING
- Registry status
- 1,590 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: People who get COVID-19 have a wide range of symptoms. They also recover from COVID-19 in different ways. In this study, researchers will use survey data to describe the different ways people experience and recover from COVID-19. They will also use the data to help create future studies to understand why some people do not fully recover. Objective: To learn more about the range and timing of symptoms that people have before, during, and after COVID-19 infection. Eligibility: People ages 18 and older who can give documentation of a positive COVID-19 or antibody test. Design: Participants will be screened with a telephone interview. It will take 15 minutes. They will provide their COVID-19 test results and medical records. Participants will complete a second telephone interview. It will take 30 60 minutes. They will also take online surveys every 3 months for 3 years. The interview and surveys will ask participants about their health before they got COVID-19, what happened while they had COVID-19, and what their recovery has been like. Participants will get log-in data to take the online surveys. Completing all of the surveys the first time may take up to 3 hours. Follow-up surveys will take up to 30 minutes. Participants do not have to complete the surveys in one sitting. They will be able to save their progress and finish the surveys later. Participants may be contacted to take part in other research studies.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,590 participants |
| Start Date | 2022-01-02 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04573062
The ClinicalTrials.gov registry entry for NCT04573062 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,590 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post-Coronavirus Disease 19 appearing as the primary indexed condition, and to 0 interventions.
NCT04573062 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04573062 about?
NCT04573062 is a clinical study titled "Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health". Background: People who get COVID-19 have a wide range of symptoms. They also recover from COVID-19 in different ways. In this study, researchers will use survey data to describe the different ways people experience and recover from COVID-19. They will also use the data to help create future studies...
What is the current status of trial NCT04573062?
This trial is currently recruiting. The enrollment target is 1,590 participants. The study started on 2022-01-02. Estimated completion is 2027-12-31.
What conditions does trial NCT04573062 study?
This clinical trial studies the following conditions: Post-Coronavirus Disease 19.
Who is sponsoring clinical trial NCT04573062?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04573062 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.